ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Mesenchymal Stem Cells Suppress Cytotoxic Activity of Natural Killer Cells in Islet Cell Transplantation

Y. Saeki, K. Ishiyama, F. Hirata, Y. Tanaka, H. Ohdan

Hiroshima University, Hiroshima, Japan

Meeting: 2013 American Transplant Congress

Abstract number: A685

Related Abstracts
  • Mesenchymal Stem Cells Suppress Cytotoxicity of Activated Natural Killer Cells in Liver Via the TRAIL-TRAIL Receptor Pathway in Islet Transplantation
  • Bone Marrow-Derived Mesenchymal Stem Cells of Neonatal Mice Suppress Dendritic Cells Maturation and T Lymphocyte Proliferation

Introduction:The immune response occurs against islet graft immediately after islet transplantation has remained a major obstacle. We have shown that both the expression of TNF-related apoptosis-inducing ligand(TRAIL) on liver natural killer(NK) cells and anti-islet cytotoxicity of liver NK cells significantly increased after intraportal islet transplantation in a mouse model, suggesting that liver NK cells play a role in the destruction of islets transplanted into the liver. To resolve this problem, we focused on mesenchymal stem cells(MSCs), which have been shown to possess immune function. We hypothesized that co-transplantation of both MSCs and islets would improve graft function by suppressing the function of liver NK cells through prostaglandin E2(PGE2) from MSCs. Methods:We prepared splenocytes and/or liver mononuclear cells(LMNCs) and bone marrow-derived MSCs from C57BL/6 mice. Quantification of PGE2 was performed using supernatants collected at different condition. To examine the suppressive effect of MSCs on activated splenic or liver NK cells, we cultured splenocytes and/or LMNCs with MSCs(MSCs group) or without MSCs(control group) in the presence of IL-2 for 3 days at various ratio. Then, cells were harvested, and cytotoxic activity against YAC-1(an NK-sensitive cell line) was confirmed by standard 51Cr-release assay. The expression of TRAIL on the NK cells was analyzed by flow cytometry.

Results:Our findings showed that the proliferation of IL-2-stimulated splenocytes and LMNCs was suppressed in a dose-dependent manner, and the proportion of TRAIL-expressing liver NK cells was significantly lesser in the MSC group than in the control group(14.0%±3.1%vs.5.7%±0.5%;p<0.05). Furthermore, the proportion of TRAIL-expressing liver NK cells was correspondingly reduced under co-culture with PGE2 when compared to the control group(24.5%±4.4%vs.19.7%±3.3%). IL-2-stimulated splenocytes and LMNCs showed potent cytotoxicity against YAC-1 when compared with fresh splenocytes and LMNCs (17.5%±0.4%vs.1.1%±0.0%and54.7%±4.1%vs.8.7%±0.6%,respectively). In contrast, the cytotoxic activity of IL-2-stimulated splenocytes showed a 10-fold reduction when these cells were co-cultured with MSCs(17.5%±0.4%vs.1.4%±1.2%). Conclusion:Our results suggest that PGE2 secretion from MSCs can suppress both activated splenic and liver NK cells via the TRAIL regulative pathway; thus, MSCs can be used for suppressing liver NK cells to prevent islet destruction in clinical islet transplantation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Saeki Y, Ishiyama K, Hirata F, Tanaka Y, Ohdan H. Mesenchymal Stem Cells Suppress Cytotoxic Activity of Natural Killer Cells in Islet Cell Transplantation [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/mesenchymal-stem-cells-suppress-cytotoxic-activity-of-natural-killer-cells-in-islet-cell-transplantation/. Accessed January 25, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.